152 related articles for article (PubMed ID: 38049338)
1. [The study of clinical characteristics and prognosis of RUNX1-RUNX1T1 positive acute myeloid leukemia based on next-generation sequencing].
Wang YL; Gao SJ; Su L; Liu YJ; Zhang YW; Du YZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):851-854. PubMed ID: 38049338
[No Abstract] [Full Text] [Related]
2. Relapsed RUNX1-RUNX1T1-positive acute myeloid leukemia with pseudo-Chediak-Higashi granules.
Kondo H; Kanayama T; Matsumura U; Urata T; Osone S; Imamura T; Inaba T; Hosoi H
Int J Hematol; 2021 May; 113(5):616-617. PubMed ID: 33782817
[No Abstract] [Full Text] [Related]
3. The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of
Jo YH; Han EA; Park SK; Jeon BR; Jang MA
Ann Lab Med; 2023 May; 43(3):315-318. PubMed ID: 36544347
[No Abstract] [Full Text] [Related]
4. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with
Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K
Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305
[No Abstract] [Full Text] [Related]
5. Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia.
Mandell JD; Fisk JN; Cyrenne E; Xu ML; Cannataro VL; Townsend JP
Leukemia; 2022 Dec; 36(12):2931-2933. PubMed ID: 36369483
[No Abstract] [Full Text] [Related]
6. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
7. Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1.
Chen D; Chen W
Br J Haematol; 2021 May; 193(4):691. PubMed ID: 33386742
[No Abstract] [Full Text] [Related]
8. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
9. The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
Swart LE; Heidenreich O
Exp Hematol; 2021 Feb; 94():1-10. PubMed ID: 33217477
[TBL] [Abstract][Full Text] [Related]
10. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
Krauth MT; Eder C; Alpermann T; Bacher U; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S
Leukemia; 2014 Jul; 28(7):1449-58. PubMed ID: 24402164
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia.
Shao H; Yang Q; Zhang P; Liu H; Wu C; Cen J; Qiu H; Chen S; Pan J
Ann Hematol; 2018 Mar; 97(3):529-531. PubMed ID: 29124313
[No Abstract] [Full Text] [Related]
12. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic value of cloned genetic mutations detected by second-generation sequencing in RUNX1-RUNX1T1 positive acute myeloid leukemia patients receiving intensive consolidation therapy].
Yu JQ; Xue SL; Li Z; Wang J; Wang C; Chu XL; Han R; Tao T; Qiu QC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):210-215. PubMed ID: 32311890
[No Abstract] [Full Text] [Related]
14. FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1-ETO and PML-RARA.
Chen M; Fu M; Wang A; Wu X; Zhen J; Gong M; Wu P; Du Q; Wang T; Liu H; Wang H
Int J Lab Hematol; 2021 Dec; 43(6):e276-e279. PubMed ID: 33943002
[No Abstract] [Full Text] [Related]
15. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
[TBL] [Abstract][Full Text] [Related]
16. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
Flach J; Shumilov E; Joncourt R; Porret N; Tchinda J; Legros M; Scarpelli I; Hewer E; Novak U; Schoumans J; Bacher U; Pabst T
Genes Chromosomes Cancer; 2020 Apr; 59(4):268-274. PubMed ID: 31756777
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic Lymphohistiocytosis in
Huang X; Long F; Zhang Y; Gao X; Li T
Turk J Haematol; 2023 Aug; 40(3):210-212. PubMed ID: 37519108
[No Abstract] [Full Text] [Related]
18. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
[TBL] [Abstract][Full Text] [Related]
19. Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study.
Xu D; Yang Y; Yin Z; Tu S; Nie D; Li Y; Huang Z; Sun Q; Huang C; Nie X; Yao Z; Shi P; Zhang Y; Jiang X; Liu Q; Yu G
Blood Cancer J; 2023 Nov; 13(1):168. PubMed ID: 37957175
[No Abstract] [Full Text] [Related]
20. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia.
Kim T; Moon JH; Ahn JS; Ahn SY; Jung SH; Yang DH; Lee JJ; Shin MG; Choi SH; Lee JY; Tyndel MS; Lee HY; Kim KH; Cai Y; Lee YJ; Sohn SK; Min YH; Cheong JW; Kim HJ; Zhang Z; Kim DDH
Sci Rep; 2020 Nov; 10(1):20119. PubMed ID: 33208771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
